Aarti Drugs Relaunches Shareholder Campaign for Unclaimed Dividends

Aarti Drugs Ltd. is relaunching its 'Saksham Niveshak' campaign to help shareholders claim potentially forgotten dividends. The initiative, active from April 1 to July 9, 2026, urges investors to update their details to prevent unclaimed funds from being transferred to the Investor Education and Protection Fund (IEPF).

Campaign Details

The 'Saksham Niveshak' initiative is active for a defined period, specifically from April 1, 2026, to July 9, 2026. Prompted by the Ministry of Corporate Affairs' Investor Education and Protection Fund Authority (IEPFA), the campaign's main goal is to assist shareholders in updating their Know Your Customer (KYC) details and claiming any dividends that remain unpaid or unclaimed. Shareholders are urged to complete these actions by the July 9, 2026, deadline to prevent their unclaimed dividends from being transferred to the IEPF.

Why Shareholders Should Act

This campaign offers a critical opportunity for shareholders to recover funds they may have overlooked. By participating, investors can ensure they receive their rightful dividends directly and prevent these amounts from being permanently transferred to the IEPF. The effort also highlights Aarti Drugs' commitment to shareholder engagement and good corporate governance.

Background: A National Drive

The 'Saksham Niveshak' campaign is part of a wider national drive by the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs. This effort aims to help investors claim their entitlements before they are transferred to the IEPF after a period of unclaimed status. Similar 100-day campaigns have recently been undertaken by companies like Hindalco Industries, Bayer India, Hindustan Unilever, and Kirloskar Industries throughout late 2025 and early 2026, responding to the IEPFA's call. Aarti Pharmalabs, a demerged entity from Aarti Industries, also launched a comparable dividend claim campaign within the same April 1 to July 9, 2026 timeframe.

Action Required from Shareholders

Shareholders with unpaid or unclaimed dividends must take action by updating their KYC, PAN, bank account details, and nomination information. This must be completed with the company's Registrar & Share Transfer Agent or their Depository Participant before the July 9, 2026 deadline.

Key Risks

The primary risk for shareholders is losing their unclaimed dividends if they do not update KYC and claim them by the July 9, 2026 deadline. Funds not claimed will be transferred to the IEPF Authority. Additionally, inaccurate or incomplete KYC details could lead to delays or prevent the successful processing of dividend claims.

Industry Context

Aarti Drugs operates in the Indian pharmaceutical sector, focusing on APIs and intermediates, alongside peers like Divi's Laboratories and Sun Pharmaceutical Industries. The 'Saksham Niveshak' campaign, however, is a company-specific initiative driven by regulatory guidance, similar to efforts by Aarti Pharmalabs and others to comply with IEPFA directives.

What Investors Should Track

Shareholders should closely monitor the July 9, 2026 deadline for updating their details and claiming dividends. They can also watch for company communications that may offer specific assistance during the campaign period. Aarti Drugs is expected to manage claims efficiently before the July 9 transfer deadline.